Skip to main content

ADVERTISEMENT

Frank J. Criado, MD

Editor's Corner
09/05/2008
Our Editor-in-Chief reflects upon our field’s “wonderful new technologies” and uses this topic as the foundation for this month’s Editor’s Corner.
Our Editor-in-Chief reflects upon our field’s “wonderful new technologies” and uses this topic as the foundation for this month’s Editor’s Corner.
Our Editor-in-Chief reflects...
09/05/2008
Vascular Disease Management
Interview
09/11/2018
Frank J. Criado, MD, FACS, FSVM, spoke about endovascular aneurysm repair at the 2018 International Symposium on Endovascular Therapy.
Frank J. Criado, MD, FACS, FSVM, spoke about endovascular aneurysm repair at the 2018 International Symposium on Endovascular Therapy.
Frank J. Criado, MD, FACS, FSVM,...
09/11/2018
Vascular Disease Management
Editor's Corner
09/05/2008
In this issue of VDM, Shammas has presented several algorithms regarding treatment of the spectrum of acute and chronic lower extremity ischemia with the emphasis refreshingly placed primarily on thrombus, platelets and “clot” management.
In this issue of VDM, Shammas has presented several algorithms regarding treatment of the spectrum of acute and chronic lower extremity ischemia with the emphasis refreshingly placed primarily on thrombus, platelets and “clot” management.
In this issue of VDM, Shammas...
09/05/2008
Vascular Disease Management
Editor's Corner
09/05/2008
It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM).
It is with a sense of pride and excitement that I set out to write the first Editor’s Letter for the inaugural issue of Vascular Disease Management (VDM).
It is with a sense of pride and...
09/05/2008
Vascular Disease Management
Editor's Corner
09/05/2008
We are literally “surrounded” by innovation, less-invasive endovascular techniques and devices. “New paradigms” emerge every couple of years, perhaps more often! Many such new technologies and therapies can be classified as disruptive.
We are literally “surrounded” by innovation, less-invasive endovascular techniques and devices. “New paradigms” emerge every couple of years, perhaps more often! Many such new technologies and therapies can be classified as disruptive.
We are literally “surrounded” by...
09/05/2008
Vascular Disease Management
Clinical Editor's Corner
08/23/2013
Patients with severe asymptomatic carotid stenosis seem to be at high risk for symptoms and even stroke in comparison to those with carotid artery stenosis in general, regardless of whether they receive optimal medical therapy, and therefore...
Patients with severe asymptomatic carotid stenosis seem to be at high risk for symptoms and even stroke in comparison to those with carotid artery stenosis in general, regardless of whether they receive optimal medical therapy, and therefore...
Patients with severe...
08/23/2013
Vascular Disease Management
Clinical Editor's Corner
07/31/2013
A successful medical debate is one that both informs and entertains its viewers.
A successful medical debate is one that both informs and entertains its viewers.
A successful medical debate is...
07/31/2013
Vascular Disease Management
Clinical Editor's Corner
06/04/2013
The US Food and Drug Administration has approved 21-French and smaller endovascular aneurysm repair (EVAR) systems to include percutaneous EVAR (PEVAR) based on the outcomes of the first prospective, multicenter, randomized PEVAR trial. The...
The US Food and Drug Administration has approved 21-French and smaller endovascular aneurysm repair (EVAR) systems to include percutaneous EVAR (PEVAR) based on the outcomes of the first prospective, multicenter, randomized PEVAR trial. The...
The US Food and Drug...
06/04/2013
Vascular Disease Management
Clinical Editor's Corner
05/03/2013
At the Charing Cross meeting, post-EVAR type II endoleak was among the top issues discussed. Management guidelines and outcome implications of type II endoleaks may not be as clear as previously thought.
At the Charing Cross meeting, post-EVAR type II endoleak was among the top issues discussed. Management guidelines and outcome implications of type II endoleaks may not be as clear as previously thought.
At the Charing Cross meeting,...
05/03/2013
Vascular Disease Management
Clinical Editor's Corner
04/03/2013
Authors of a meta-analysis on small abdominal aortic aneurysms found that aneurysm growth and rupture rates varied considerably across the various studies.
Authors of a meta-analysis on small abdominal aortic aneurysms found that aneurysm growth and rupture rates varied considerably across the various studies.
Authors of a meta-analysis on...
04/03/2013
Vascular Disease Management